What is CJC-1295 Without DAC?

CJC-1295 Without DAC is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH) designed for research into pulsatile peptide signalling and receptor pathway activation. Unlike the DAC-modified version, this peptide does not bind to albumin, resulting in a shorter active duration, making it suitable for studies examining transient receptor activation and controlled peptide kinetics. CJC-1295 Without DAC is supplied in a lyophilised form to preserve peptide integrity for in vitro research applications.

Research Applications

• Study of GHRH receptor interactions
• In vitro investigation of pulsatile peptide activity
• Research into peptide degradation pathways
• Analysis of short-acting peptide analogues

Key Features

• Available in 5 mg and 10 mg vials
• Non-DAC formulation for shorter half-life research
• ≥98% purity (HPLC certified)
• Batch-specific Certificate of Analysis available

Specifications

Reconstitution & Handling

• Reconstitute with bacteriostatic water or another sterile solvent suitable for laboratory use
• Gently swirl until peptide is fully dissolved
• Avoid foaming or vigorous agitation

Quality & Testing

Each batch of CJC-1295 Without DAC is analysed using HPLC and mass spectrometry to validate purity, identity, and molecular integrity. Batch traceability and Certificates of Analysis (COA) are provided for research compliance.

Important Notice

For laboratory research use only. Not for human or veterinary use, diagnostic procedures, or therapeutic applications.